Basta Steven L

Phathom Pharmaceuticals, Inc. · President and CEO

Basta Steven L is listed in public filings as director, officer: President and CEO. This Basta Steven L insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Phathom Pharmaceuticals, Inc. (PHAT), and VYNE Therapeutics Inc. (VYNE). Investors use Basta Steven L's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Phathom Pharmaceuticals, Inc.PHAT--379.6k sharesGrant / ExerciseFeb 10, 2026Disclosure amount unavailable12.4k shares----
Phathom Pharmaceuticals, Inc.PHAT$4.8M373.3k sharesGrant / ExerciseFeb 10, 2026$80.5K6.3k shares$12.82--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Phathom Pharmaceuticals, Inc.PHAT$3.5M221.2k sharesGrant / ExerciseJan 2, 2026$3.6M226.2k shares$15.71--
Phathom Pharmaceuticals, Inc.PHAT--364.8k sharesGrant / ExerciseJan 2, 2026Disclosure amount unavailable251k shares----
Phathom Pharmaceuticals, Inc.PHAT$1.7M113.8k sharesGrant / ExerciseDec 17, 2025$483.9K31.5k shares$15.36--
Phathom Pharmaceuticals, Inc.PHAT--145.3k sharesGrant / ExerciseDec 17, 2025Disclosure amount unavailable62k shares----
VYNE Therapeutics Inc.VYNE$7.5k20k sharesGrant / ExerciseDec 12, 2025$7.5K20k shares$0.3756--
Phathom Pharmaceuticals, Inc.PHAT$1.3M83.3k sharesGrant / ExerciseNov 28, 2025$755.6K48.4k shares$15.62--
Phathom Pharmaceuticals, Inc.PHAT--131.6k sharesGrant / ExerciseNov 28, 2025Disclosure amount unavailable90k shares----
Phathom Pharmaceuticals, Inc.PHAT$485k41.6k sharesGrant / ExerciseSep 25, 2025$564.1K48.4k shares$11.66--
Phathom Pharmaceuticals, Inc.PHAT--90k sharesGrant / ExerciseSep 25, 2025Disclosure amount unavailable90k shares----
Phathom Pharmaceuticals, Inc.PHAT$5.4M1.1M sharesGrant / ExerciseApr 3, 2025$5.4M1.1M shares$5.01--
Phathom Pharmaceuticals, Inc.PHAT--360k sharesGrant / ExerciseApr 3, 2025Disclosure amount unavailable360k shares----
VYNE Therapeutics Inc.VYNE$48k20k sharesGrant / ExerciseDec 12, 2024$48.0K20k shares$2.40--